Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DR. REDDYS LAB ALKEM LABORATORIES/
DR. REDDYS LAB
 
P/E (TTM) x 37.5 19.7 190.3% View Chart
P/BV x 6.5 4.4 147.2% View Chart
Dividend Yield % 1.0 0.6 155.7%  

Financials

 ALKEM LABORATORIES   DR. REDDYS LAB
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
DR. REDDYS LAB
Mar-23
ALKEM LABORATORIES/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3,6254,656 77.9%   
Low Rs2,8353,788 74.9%   
Sales per share (Unadj.) Rs970.11,481.4 65.5%  
Earnings per share (Unadj.) Rs84.2270.7 31.1%  
Cash flow per share (Unadj.) Rs110.2345.7 31.9%  
Dividends per share (Unadj.) Rs50.0040.00 125.0%  
Avg Dividend yield %1.50.9 163.4%  
Book value per share (Unadj.) Rs756.41,389.6 54.4%  
Shares outstanding (eoy) m119.57166.53 71.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.32.8 116.8%   
Avg P/E ratio x38.415.6 245.9%  
P/CF ratio (eoy) x29.312.2 240.1%  
Price / Book Value ratio x4.33.0 140.5%  
Dividend payout %59.414.8 401.8%   
Avg Mkt Cap Rs m386,207703,039 54.9%   
No. of employees `000NANA-   
Total wages/salary Rs m21,31446,466 45.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,993246,697 47.0%  
Other income Rs m2,16110,555 20.5%   
Total revenues Rs m118,153257,252 45.9%   
Gross profit Rs m15,06563,860 23.6%  
Depreciation Rs m3,10412,502 24.8%   
Interest Rs m1,0741,428 75.2%   
Profit before tax Rs m13,04860,485 21.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,98015,412 19.3%   
Profit after tax Rs m10,06845,073 22.3%  
Gross profit margin %13.025.9 50.2%  
Effective tax rate %22.825.5 89.6%   
Net profit margin %8.718.3 47.5%  
BALANCE SHEET DATA
Current assets Rs m86,064203,161 42.4%   
Current liabilities Rs m37,07185,721 43.2%   
Net working cap to sales %42.247.6 88.7%  
Current ratio x2.32.4 98.0%  
Inventory Days Days3379 41.1%  
Debtors Days Days67107 62.6%  
Net fixed assets Rs m37,245112,638 33.1%   
Share capital Rs m239833 28.7%   
"Free" reserves Rs m90,208230,571 39.1%   
Net worth Rs m90,447231,404 39.1%   
Long term debt Rs m01,278 0.0%   
Total assets Rs m124,541315,799 39.4%  
Interest coverage x13.243.4 30.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.8 119.2%   
Return on assets %8.914.7 60.8%  
Return on equity %11.119.5 57.1%  
Return on capital %15.626.6 58.7%  
Exports to sales %14.652.2 27.9%   
Imports to sales %016.8 0.0%   
Exports (fob) Rs m16,916128,803 13.1%   
Imports (cif) Rs mNA41,484 0.0%   
Fx inflow Rs m16,916128,803 13.1%   
Fx outflow Rs m4,19041,484 10.1%   
Net fx Rs m12,72787,319 14.6%   
CASH FLOW
From Operations Rs m16,82558,875 28.6%  
From Investments Rs m1,128-41,373 -2.7%  
From Financial Activity Rs m-17,608-26,861 65.6%  
Net Cashflow Rs m416-9,073 -4.6%  

Share Holding

Indian Promoters % 56.7 26.7 212.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.4 47.3 51.6%  
FIIs % 8.5 28.6 29.7%  
ADR/GDR % 0.0 15.3 -  
Free float % 43.3 58.0 74.6%  
Shareholders   65,184 257,794 25.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on ALKEM LABORATORIES vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Dr. Reddys Share Price Performance

Period ALKEM LABORATORIES Dr. Reddys S&P BSE HEALTHCARE
1-Day -1.18% 1.78% 1.18%
1-Month -0.99% -4.23% -0.75%
1-Year 52.26% 35.93% 61.82%
3-Year CAGR 21.70% 10.85% 18.16%
5-Year CAGR 22.99% 17.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

Dr. Reddys paid Rs 40.0, and its dividend payout ratio stood at 14.8%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.